{"SPADE_UN_11348": {"Clinical Information": [{"Medical use": "①Prevention of acute kidney injury after cardiac surgery; ②Treatment of sepsis.", "Company": "Action Pharma A/S (Aarhus and Copenhagen, Denmark)", "Stage of Development": "Phase II (Completed)", "Comments": "No more comments", "Clinical Trials": ["NCT00628264", "NCT00903604", "NCT01256372"]}], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11348", "Peptide Name": "AP-214(Modimelanotide)", "Sequence": "KKKKKKSYSMEHFRWGKPV", "Source": "Synthetic derivative from HDP α-melanocyte-stimulating hormone", "Target Organism": "No MICs found on DRAMP database", "Reference": ["AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality.(PMID:18354376)"], "Biological Activity": ["Antibacterial"], "Frequent Amino Acids": "KSE", "Absent Amino Acids": "ACDILNOQTU", "Basic Residues": 9, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 13, "Positive Residues": 9, "Negative Residues": 1, "Mass": 2392.87, "PI": 10.47, "Net Charge": 8, "Hydrophobicity": -1.86, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08584", "Similarity": 1.0, "Sequence": "KKKK"}, {"SPADE_ID": "SPADE_N_10106", "Similarity": 1.0, "Sequence": "FKFKKKKKKK"}, {"SPADE_ID": "SPADE_N_10107", "Similarity": 1.0, "Sequence": "GFGKGFGKKKKKK"}]}}}